A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: Case report

被引:7
作者
Autorino, R.
Lamendola, M. G.
De Sio, M.
Di Trolio, R. A.
Ferraraccio, F.
Di Lorenz, G.
机构
[1] Univ Naples 2, Dept Urol, Naples, Italy
[2] Univ Naples 2, Dept Pathol, Naples, Italy
[3] Univ Naples Federico 2, Dept Dermatol, Naples, Italy
[4] Univ Naples Federico 2, Dept Oncol, Naples, Italy
关键词
testis cancer; primary lymphoma; biological therapy; rituximab; TESTICULAR LYMPHOMA;
D O I
10.1177/039463200702000222
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Primary testicular lymphoma is an uncommon testicular tumour. We present a case of a primary non-Hodgkin lymphoma of the testis, describing its clinical and pathological features and discussing our treatment strategy. A 68-year-old man showed a firm erythematous testicular mass within the right emiscrotum. Subsequent ultrasonography demonstrated a right inferior pole testicular mass with disomogenously hypoecogenic. The patient was submitted to inguinal orchidectomy. Light microscopy demonstrated the classic appearance of a diffuse large B-cell lymphoma. The immunohistochemical study showed tumour cells intensively positive for CD45, Ki67 and CD20. No evidence of extra-testicular involvement by lymphoma was found. At 6 months, a TC-PET showed a clinical relapse in lung and abdominal lymphonodes, while clinical examination demonstrated a single, indolent and erythematous nodule in the left foot. The histologic analysis confirmed diagnosis of CD-20 positive B-cell lymphoma. The patient was treated with an anti-CD 20 monoclonal antibody (rituximab) alone every 3 weeks. After 3 months a complete response was observed in all sites of disease. The patient was free from disease at 12 months follow-up.
引用
收藏
页码:401 / 403
页数:3
相关论文
共 7 条
[1]
Darby S, 2005, INT J ONCOL, V26, P1093
[2]
MALIGNANT-LYMPHOMA OF THE TESTIS [J].
DOLL, DC ;
WEISS, RB .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (03) :515-524
[3]
Testicular lymphoma - A retrospective, population-based, clinical and immunohistochemical study [J].
Hasselblom, S ;
Ridell, B ;
Wedel, H ;
Norrby, K ;
Baum, MS ;
Ekman, T .
ACTA ONCOLOGICA, 2004, 43 (08) :758-765
[4]
LYMPHOMA AND LEUKEMIA INVOLVING THE TESTICLES - FINDINGS ON GRAY-SCALE AND COLOR DOPPLER SONOGRAPHY [J].
MAZZU, D ;
JEFFREY, RB ;
RALLS, PW .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1995, 164 (03) :645-647
[5]
Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].
McLaughlin, P ;
Grillo-López, AJ ;
Link, BK ;
Levy, R ;
Czuczman, MS ;
Williams, ME ;
Heyman, MR ;
Bence-Bruckler, I ;
White, CA ;
Cabanillas, F ;
Jain, V ;
Ho, AD ;
Lister, J ;
Wey, K ;
Shen, D ;
Dallaire, BK .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833
[6]
Shahab N, 1999, SEMIN ONCOL, V26, P259
[7]
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group [J].
Zucca, E ;
Conconi, A ;
Mughal, TI ;
Sarris, AH ;
Seymour, JF ;
Vitolo, U ;
Klasa, R ;
Ozsahin, M ;
Mead, GM ;
Gianni, MA ;
Cortelazzo, S ;
Ferreri, A ;
Ambrosetti, A ;
Martelli, M ;
Thiéblemont, C ;
Moreno, HG ;
Pinotti, G ;
Martinelli, G ;
Mozzana, R ;
Grisanti, S ;
Provencio, M ;
Balzarotti, M ;
Laveder, F ;
Tean, G ;
Callea, V ;
Roy, P ;
Cavalli, F ;
Gospodarowicz, MK .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :20-27